| |
Abbvie HCV Therapy 'IEKIRA PAK' - FDA Product Insert
|
| |
| |
FDA Product Insert/Label
AbbVie's VIEKIRA PAK (ombitasvir, paritaprevir, and ritonavir tablets, dasabuvir tablets) FDA approved today by FDA.
VIEKIRAPAK with or without ribavirin is indicated for the treatment of patients with genotype 1 chronic hepatitis C virus (HCV) infection including those with compensated cirrhosis.
link to the US prescribing label characterizing the safety and efficacy information supporting approval by the FDA.
http://www.rxabbvie.com/pdf/viekirapak_pi.pdf
|
|
| |
| |
|
|
|
